News
4d
Clinical Trials Arena on MSNAscletis’s daily acne tablet set for China review after Phase III winThe Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to ...
"I left it in hope that it’d go away and after a while those ... "I was on the recommend dosage of eight tablets a day and by week three my acne had cleared up. "I continued to take eight ...
"I left it in hope that it’d go away and after a while those ... "I was on the recommend dosage of eight tablets a day and by week three my acne had cleared up. "I continued to take eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results